Furthermore, bone marrow smears demonstrated a significant reduction in leukemia cells in the MMP14 inhibitor combined with cytarabine group, and infiltration of splenic leukemia cells was diminished as evidenced by histological H&E staining (Fig. 6F). Here, MMP14 is linked to leukemia.